SVR results of a once-daily regimen of simeprevir (TMC435) plus sofosbuvir (GS-7977) with or without ribavirin in cirrhotic and non-cirrhotic HCV genotype 1 treatment-naive and prior null responder patients: The COSMOS studyIra M. Jacobson,Reem H. Ghalib,Maribel Rodriguez-Torres,Zobair M. Younossi,Ana Corregidor,Mark S. Sulkowski,Edwin DeJesus,Brian Pearlman,Mordechai Rabinovitz,Norman Gitlin,Joseph K. Lim,Paul J. Pockros,Bart Fevery,Tom Lambrecht,Sivi Ouwerkerk-Mahadevan,Katleen Callewaert,William T. Symonds,Gaston Picchio,Karen Lindsay,Maria Beumont-Mauviel,Eric LawitzHepatology（2013）引用 27|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
